Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Inventory (2016 - 2025)

Historic Inventory for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $40.7 million.

  • Xtant Medical Holdings' Inventory fell 279.81% to $40.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.7 million, marking a year-over-year decrease of 279.81%. This contributed to the annual value of $38.6 million for FY2024, which is 474.18% up from last year.
  • Latest data reveals that Xtant Medical Holdings reported Inventory of $40.7 million as of Q3 2025, which was down 279.81% from $40.1 million recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Inventory peaked at $41.9 million during Q3 2024, and registered a low of $16.5 million during Q2 2022.
  • Over the past 5 years, Xtant Medical Holdings' median Inventory value was $21.6 million (recorded in 2021), while the average stood at $28.3 million.
  • Its Inventory has fluctuated over the past 5 years, first crashed by 3860.44% in 2021, then soared by 11339.31% in 2023.
  • Xtant Medical Holdings' Inventory (Quarter) stood at $17.9 million in 2021, then decreased by 3.68% to $17.3 million in 2022, then skyrocketed by 113.39% to $36.9 million in 2023, then increased by 4.74% to $38.6 million in 2024, then rose by 5.38% to $40.7 million in 2025.
  • Its last three reported values are $40.7 million in Q3 2025, $40.1 million for Q2 2025, and $38.8 million during Q1 2025.